Imaging of nitric oxide in the retina  by Eldred, William D. & Blute, Todd A.
www.elsevier.com/locate/visres
Vision Research 45 (2005) 3469–3486Imaging of nitric oxide in the retina q
William D. Eldred *, Todd A. Blute
Laboratory of Visual Neurobiology, Department of Biology, Boston University, 5 Cummington Street, Boston, MA 02215, USA
Received 13 June 2005; received in revised form 22 July 2005Abstract
Nitric oxide (NO) is the most widespread signaling molecule found in the retina in that it can be made by every retinal cell type.
NO is able to inﬂuence a wide variety of synaptic mechanisms ranging from increasing or decreasing neurotransmitter release to the
modulation of gap junction conductivity. Although biochemical methods can analyze overall levels of NO, such methods cannot
indicate the speciﬁc cell types involved. In the last few years, ﬂuorescent imaging methods utilizing diaminoﬂuorescein have allowed
the real-time visualization of neurochemically or light stimulated NO-induced ﬂuorescence (NO-IF) in speciﬁc retinal cells. Recent
experiments have shown that this NO-IF can be stabilized using paraformaldehyde ﬁxation. This aldehyde stabilization has allowed
the imaging of NO production in the dark and in response to light, as well as the neurochemical modulation of light stimulated NO
production. The results of these studies indicate that NO is not always freely diﬀusible and that NO is largely retained in many cells
which make it. The NO production in retina is highly damped in that in the absence of stimulation, the endogenous levels of NO
production are extremely low. Finally, diﬀerent neurochemical or light stimulation protocols activate NO production in speciﬁc cells
and subcellular compartments. Therefore, although the NO signaling is widespread in retina, it is very selectively activated and has
diﬀerent functions in speciﬁc retinal cell types. The use of NO imaging will continue to play a critical role in future studies of the
function of NO in retina and other neural systems.
 2005 Elsevier Ltd. All rights reserved.
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The retina is a massively parallel analog visual pro-
cessing computer that uses a wide variety of neurotrans-
mitters and millions of synaptic connections. A large
percentage of these connections involve conventional
neurotransmitter release at anatomically deﬁned synap-
tic connections onto well characterized and localized
receptors to produce postsynaptic changes in electrical
activity at the millisecond time scale. However, many
of these same transmitters and receptors can also acti-
vate biochemical signal transduction systems which pro-0042-6989/$ - see front matter  2005 Elsevier Ltd. All rights reserved.
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E-mail address: eldred@bu.edu (W.D. Eldred).cess this same information at the millisecond to minutes
time scales. In recent years, it has become apparent that
the nitric oxide (NO)/cyclic guanosine monophosphate
(cGMP) signaling pathway is one of the most wide-
spread in the retina (Eldred, 2000). This pathway is dis-
tinguished by having NO produced on demand, that NO
is not released using synaptic vesicles, and that NO does
not bind to speciﬁc receptors on the postsynaptic mem-
brane. Basically, any synaptic mechanism that can in-
crease intracellular calcium either directly through
receptor channels or by release from intracellular stores
can potentially activate this pathway. This increased cal-
cium can activate calmodulin which in turn activates
either endothelial nitric oxide synthase (eNOS) or neu-
ronal nitric oxide synthase (nNOS) to synthesize NO.
NO has been shown to inﬂuence the physiology of all
neuronal types in the retina. The most clearly
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has been the activation of soluble guanylate cyclase
(sGC) to synthesize cGMP. For instance, NO has been
shown to increase the gain and extend the voltage range
of exocytosis in cone photoreceptors (Rieke & Schwartz,
1994; Savchenko, Barnes, & Kramer, 1997). In bipolar
cells, NO donor produces an inward current accompa-
nied by a rise in dim and bright ﬂash response ampli-
tudes, and an increase in membrane conductance
(Shiells & Falk, 1992). Cyclic GMP has recently been
shown to selectively enhance responses to dim, but not
bright, stimuli through a purely postsynaptic mechanism
that is blocked by inhibitors of cGMP-dependent kinase
(Snellman & Nawy, 2004). These last authors propose
that cGMP-dependent kinase decreases coupling of the
ON-bipolar cell metabotropic glutamate receptors to
their downstream signaling cascade, which has the eﬀect
of amplifying small decreases in photoreceptor transmit-
ter release.
Perhaps the most comprehensive studies have exam-
ined the role of NO in horizontal cells. Miyachi, Mura-
kami, and Nakaki (1990), report that injection of the
NO precursor, L-arginine, into H1 luminosity-type hor-
izontal cells in turtle retina reduces their light responses,
dramatically increases their input resistance, decreases
their response to a surround, and increases their re-
sponse to stimulation of their receptive ﬁeld center.
McMahon and Ponomareva (1996) report that bath
application of L-arginine also decreases the kainate
responses in H1 cells in a manner similar to cGMP
and NO. Thus, it is likely that the H1 horizontal cells
can serve as their own source and target of NO to neg-
atively modulate the gain at photoreceptor-horizontal
cell synapses. Finally, Yu and Eldred (2003) have shown
that GABAA and GABAC receptor antagonists increase
retinal cGMP levels through the activation of nitric
oxide synthase (NOS) and that NO stimulates GABA
release and inhibits glycine release in retina (Yu & El-
dred, 2005). The NO stimulated GABA release from
horizontal cells was shown to be due to the reversal of
the GABA uptake transporter.
In amacrine cells, Mills and Massey (1995) conclude
that by working through cGMP, the NO released by
light stimulation (Koistinaho, Swanson, de Vente, & Sa-
gar, 1993) decreases the rod input and increases the cone
input during light adaptation by uncoupling the AII
amacrine cells from the cone bipolars. Wexler, Stanton,
and Nawy (1998) demonstrate that NO can depress GA-
BAA receptor function on amacrine cells. They conclude
that NO stimulates sGC to increase cGMP levels, which
then increases phosphorylation through protein kinase
G to depress GABA currents. The increased cGMP also
stimulates a cGMP-activated phosphodiesterase to de-
crease cAMP levels and phosphorylation through pro-
tein kinase A. Wexler et al. (1998) conclude that
activators of adenylate cyclase, like dopamine, enhanceGABAA currents, while activators of guanylate cyclase,
like NO, do the opposite, and therefore cAMP and NO/
cGMP function in a push-pull mechanism in GABAer-
gic transmission in these amacrine cells. NO also modu-
lates cyclic nucleotide gated channels by activating a
NO-sensitive sGC to increase levels of cGMP in photo-
receptors (Savchenko et al., 1997), bipolar cells (Shiells
& Falk, 1992), and ganglion cells (Ahmad et al., 1994).
Finally, Wang, Liets, and Chalupa (2003) report that
bath application of L-arginine or NO donor usually
reduces the peak discharge rates of ON responses in
ganglion cells by about 40%, and completely blocks
the OFF responses in most ganglion cells.
Clearly, the NO/cGMP signaling system is critical for
many aspects of retinal function and it will be important
to understand its role in speciﬁc retinal cell types. In par-
ticular, it will be important to analyze which cells con-
tain speciﬁc NOS isoforms, what stimuli can activate
NO production in identiﬁed cells, and what downstream
signaling pathways are activated by the NO that is pro-
duced. Answers to these questions have been facilitated
through the use of isoform speciﬁc nNOS antisera, ﬂuo-
rescent imaging methods to image NO in retina (Blute,
Lee, & Eldred, 2000), and the use of antiserum directed
against cyclic guanosine monophosphate (cGMP). This
report will describe the methods used for NO imaging
and how they can be combined with the study of speciﬁc
NOS isoforms and the cGMP signaling systems down-
stream from NO. It will also provide the light and elec-
tron microscopic localizations of nNOS in the retina
that are necessary to put the NO imaging in perspective.2. Methods
2.1. Imaging hardware and software
The images in this report were captured using one of
three camera/imaging software packages. The ﬁrst was
an Apogee AP-7 cooled, thinned, back-illuminated
CCD camera with 512 · 512 pixel resolution (Apogee
Instruments, Auburn, CA) controlled with MaxIm DL
CCD imaging software (Cyanogen Productions, Otta-
wa, Ont.). This camera was attached to an Olympus
BH-2 epiﬂuorescence microscope with the normal ﬁlters
for ﬂuorescein. This camera system has very high sensi-
tivity but a slow frame acquisition rate (one 16 bit
frame/10 s). The second and third systems were attached
to a conventional Olympus BX-51WI ﬂuorescence
microscope with a 75 xenon arc lamp (Oriel lamp hous-
ing, Oriel, Irvine, CA; Opti Quip model 1600 power sup-
ply, Opti Quip; Highlands Mills, NY). The ﬁlters used
for NO-IF are an Omega 475 nm ±40 nm excitation ﬁl-
ter (XF1073), the appropriate dichroic mirror (XF
2010), and a 515–575 nm bandpass emission ﬁlter
(XF3010) (Omega Optical Brattleboro, VT). The second
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camera (Olympus) with 640 · 480 pixel resolution, driv-
en by Merlin imaging software (Life Science Resources)
that provided control over the 12-bit TIFF image cap-
ture (up to 4 frames per second). Finally, our current
system camera is a Hamamatsu Orca II-ER CCD cam-
era (Hamamatsu, K.K., Japan) with 1344 · 1024 pixel
resolution controlled by UltraView software (Perkin-El-
mer, Boston, MA) (Perkin-Elmer). The exact camera
speciﬁcations in terms of sensitivity, integration time,
and bit depth are not overly critical because the
NO-IF signal is quite strong. Any imaging setup which
can be used to image ﬂuorescein isothiocyanate ﬂuores-
cence can be used to image NO-induced ﬂuorescence
(NO-IF).
2.2. Tissue preparation, stimulation, ﬁxation, and NO
imaging
Larval tiger salamanders (Ambystoma tigrinum) or
adult turtles (Pseudemys scripta elegans) were main-
tained on 12 h light/12 h dark cycles. These animals
were decapitated near the middle of the light phase of
their light–dark cycle, using a method approved by the
Boston University Charles River Campus Institutional
Animal Care and Use Committee, and their eyes were
quickly removed and hemisected. For light microscopy,
the isolated eyecups were ﬁxed in 4% paraformaldehyde
in 0.1 M phosphate buﬀer (PB, pH 7.4) for 60–90 min
and then processed as previously described (Blute, May-
er, & Eldred, 1997) to produce 14 lm thick cross-sec-
tions on slides. For electron microscopy, the isolated
eyecups were processed as previously described using a
sequential low pH-high pH paraformaldehyde ﬁxation
protocol (Eldred, Zucker, Karten, & Yazulla, 1983).
After ﬁxation, the retinas were cryoprotected using a
graded sucrose/glycerol buﬀer series before being frozen
and then sectioned using a sliding microtome with a
freezing stage into 70 lm thick tangential sections.
Animals used for NO imaging were dark adapted
overnight and were maintained in total darkness by
using infrared imaging equipment throughout the prep-
aration, dye loading, and pharmacological stimulation
treatments of the retinal slices. Retinal slices were pre-
pared as described previously (Lukasiewicz, Maple, &
Werblin, 1994). Brieﬂy, the eyes were enucleated and
the anterior portion of the eye and lens were removed,
the eyecup was hemisected, placed vitreous side down
on nitrocellulose ﬁlters, and sectioned into 250 lm thick
slices. Slices were allowed to recover from slicing for at
least 30 min and then incubated for 60 min in Ringer
solution (110 mM NaCl, 2.5 mM KCl, 3 mM CaCl2,
2 mM MgCl2, 10 mM glucose, and 5 mM Hepes, pH
7.6) containing 10 lM of the NO-sensitive dye 4-ami-
no-5-methylamino-2 0,7 0-diﬂuoroﬂuorescein diacetate
(DAF) (Molecular Probes, Eugene, Oregon) with orwithout the following: 1 mM L-arginine, or the NOS
inhibitors 100 lM N-nitro-monomethyl-L-arginine (L-
NMMA), 100 lM 7-nitroindazole (7-NI), or 100 lM
S-methyl-L-thiocitrulline (SMTC). The slices were
washed for 45 min with fresh aerated Ringer and then
placed into light tight boxes that were ﬁtted with a ﬁber
optic attachment. Some slices were stimulated for
10 min with a light emitting diode to produce either
ﬂashing (660 nm, 3 Hz, 20 lW, 25% duty cycle) or stea-
dy light (660 nm, 20 lW) stimulation, while a matched
set of slices were kept in the dark for comparison. In
other cases, after loading with DAF the slices were
pharmacologically stimulated in room light with the
following drugs: the NO donor (±)-S-nitroso-N-acetyl-
penicillamine (SNAP, 100 lM), bicuculline (10–
100 lM), picrotoxin (10–100 lM), or nicotine (50 lM).
In some cases, the NO-IF was observed real-time
using a conventional ﬂuorescence microscope equipped
with excitation and emission ﬁlters normally used to
view ﬂuorescein. In the kinetic studies presented here
the ﬂuorescent images were captured of the NO-IF in
the slices using an OlymPix FK1300 cooled CCD cam-
era driven by Merlin imaging software. The data was
plotted using the Origin graphing package (Northhamp-
ton, MA). In other cases, following light or pharmaco-
logical stimulation the slices were then ﬁxed in the
dark for 2 h with 4% paraformaldehyde in 0.1 M phos-
phate buﬀer (PB, pH 7.4) and then washed in PB. The
NO-IF was then imaged using an Olympus Fluoview
300 confocal microscope and its associated Fluoview
software. The images of NO-IF are presented in reverse
contrast such that the NO-IF is dark. In some cases the
three-dimensional rendering software on a Zeiss
LSM510NLO two-photon confocal microscope was
used to analyze the confocal stacks obtained from the
Olympus confocal microscope.
2.3. Neuronal NOS immunocytochemistry
The same reagents and general methods were used for
both the light and electron immunocytochemistry. The
cryostat sections were processed on the slides. The
non-speciﬁc binding was eliminated by blocking the sec-
tions using a combination of 10% normal goat serum
and an avidin/biotin-blocking kit (Vector Laboratories,
Burlingame, CA). For the light microscopy, we em-
ployed two diﬀerent rabbit primary neuronal NOS
(nNOS) antisera that were each used at a dilution of
1:5000. The ﬁrst was directed against rat nNOS (SC-
648, Santa Cruz Biotechnology, Santa Cruz, CA), while
the second was raised against porcine cerebellar nNOS
(Mayer, Mathias, & Bo¨hme, 1990). The retinal sections
were then processed using Vector Elite ABC reagents
(Vector Laboratories, Burlington, CA) diluted 1:1000
and Immunopure Metal Enhanced DAB substrate
(Pierce Chemical, Rockford, IL). For confocal
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using 1:500 goat anti-rabbit Alexa 568 secondary antise-
rum (Molecular Probes). There was no labeling in unla-
beled control tissues when the primary antiserum was
omitted, or when the primary antiserum was preincubat-
ed with the peptide fragments against which the primary
antiserum were raised.
2.4. Neuronal NOS electron microscopy
The 70-lm thick tangential sections for electron
microscopy were processed as free-ﬂoating sections
using the SC-648 nNOS antiserum. We chose to use
the nNOS antiserum from Santa Cruz because it was
less negatively inﬂuenced by the ﬁxation required for
electron microscopy. After several rinses in PB, the
immunostained tangential sections were ﬂattened and
post-ﬁxed in 1% osmium in PB for 90 min. Following
several rinses in PB, the sections were dehydrated using
an acetone series and embedded in Medcast Araldite 502
resin (Ted Pella, Redding, CA) between plastic sheets.
Areas of interest were cut from the ﬂattened retinas
and re-embedded to allow cutting of cross-sections.
The thin sections were examined without heavy metal
counterstain using a Philips 410 electron microscope.
The subsequent negatives were digitally scanned using
a ﬂat-bed scanner and the ﬁgures were arranged and la-
beled using Corel Draw 11 software (Corel, Ottawa,
Ontario, Canada).
2.5. Cyclic GMP immunocytochemistry
All antisera solutions were diluted in PB with 0.3%
Triton X-100 (PBtx). Following imaging of NO-IF,
some slices were incubated in 1.5% normal goat serum
for 60 min, and then for three days in a rabbit-derived
primary antiserum (used at 1:500) directed against
cGMP (de Vente, Steinbusch, & Schipper, 1987). Fol-
lowing several washes in PB, the slices were incubated
in 1:500 goat anti-rabbit Alexa 568 (Molecular Probes).
Incubation of this same cGMP antiserum with free
cGMP has been previously shown to eliminate all stain-
ing (Blute, Velasco, & Eldred, 1998). The cGMP-LI was
then imaged using an Olympus Fluoview 300 confocal
microscope and its associated Fluoview software.
2.6. Comparison of real-time and paraformaldehyde ﬁxed
NO-IF
Imaging NO using DAF requires the use of bright
light sources to view the increased NO-IF in the pres-
ence of NO. This would normally preclude the use of
DAF to image NO production in the dark. Previous
studies have shown that aldehydes can be used to stabi-
lize activated DAF in tissues (Kasim, Branton, &
Clarke, 2001; Sugimoto, Fujii, Takemasa, & Yamashita,2000). We reasoned that we could use aldehyde ﬁxation
to stabilize the activated DAF to visualize the NO-IF
produced in the dark using conventional confocal
microscopy. However, this DAF ﬁxation protocol has
not been applied previously to examine retinal slices.
To validate our method, we performed control ﬁxation
experiments to show that the ﬁxation did not non-specif-
ically increase NO-IF and that ﬁxation did not alter the
localization of NO-IF. For these experiments, we pre-
pared salamander retinal slices and loaded them with
DAF as described above. To simplify these experiments,
the retinas were stimulated with 50 lM nicotine in Ring-
er for 10 min. Immediately, following this pharmacolog-
ical stimulation, ﬂuorescent images were captured of the
NO-IF in the slices using a Hamamatsu Orca ER CCD
camera attached to an Olympus BW50WI microscope
equipped with epiﬂuorescence illumination. Following
this initial imaging, the Ringer covering the slices was re-
placed with 4% paraformaldehyde in PB. Subsequent
ﬂuorescent images were obtained of the same slices while
still in ﬁxative after 30 min.
2.7. NO-selective electrode measurements
Measurement of the levels of NO near individual ret-
inal neurons were made using the Mark II ISO-NO NO
meter in combination with an ISO-NOPNM NanoSen-
sor NO-selective probe which is reported to have a tip
diameter of 0.1 lm and a detection limit for NO of less
than 0.5 nM (World Precision Instruments, Sarasota,
FL). The probe was held using a micromanipulator
and the tip was visually placed near the cell to be mea-
sured. Before each experiment, the meter and probe
combination were calibrated using a standard curve of
known concentrations of NO. The calibration was done
using decomposition of a S-nitrosothiol compound
using Cu (I) as a catalyst (www.wpiinc.com, World Pre-
cision Instruments). The output of the NO meter was
recorded through a Cambridge Electronics Designs
(Cambridge, UK) Micro 1401 A/D computer interface
running their Spike 2 electrophysiology software.3. Results
Both the light and electron microscopic localizations
of nNOS-LI in the turtle retina have been reported pre-
viously in detail (Blute et al., 1997; Cao & Eldred, 2001;
Haverkamp & Eldred, 1998), but they will be brieﬂy re-
viewed here to allow the subsequent NO imaging to be
put into perspective.
3.1. Light microscopic localization of nNOS
In these studies we used an older lot of Santa Cruz
nNOS (SC-648) primary antiserum for the immunocyto-
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lot of this same antiserum does not produce this same
high quality staining. When we used our lot of the SC-
648 antiserum in turtle it was possible to clearly distin-
guish three distinct amacrine cell types with nNOS-like
immunoreactivity (nNOS-LI, Figs. 1A–C). The type 1
nNOS amacrine cells (Fig. 1A) were relatively common
and in retinal cross-sections they had large vertically ori-
ented darkly staining pyriform shaped somata with rel-
atively symmetric dendritic arborizations. Their
processes in the deeper portions of the inner plexiform
layer (IPL) were studded with boutons. The type 2 ama-
crine cells (Fig. 1B) were the most common of the three
nNOS amacrine cell types in the turtle retina. These cells
had smallish, moderately stained, rounded somata that
gave rise to several delicate processes, which ran a short
distance in the outer IPL, before branching extensively
in the central IPL and giving rise to terminal processes
deep in the IPL or among the somata in the ganglion cell
layer (GCL). Finally, the type 3 amacrine cells (Fig. 1C)
had large, ﬂattened, oval somata that often gave rise to
thick, faintly labeled primary processes that arborized in
the outer IPL. The type 1 and 2 amacrine cell types in
turtle were very similar to the ND1 and ND2 (VaneyFig. 1. At the LM level in turtle retina, strong nNOS-LI was present in at leas
type 3 in C), their processes in the IPL (asterisks in A–C), some somata in
(asterisks in D) and near the OLM (horizontal arrowheads in D). Some am
numerous amacrine somata had weaker nNOS-LI. The sections in (A–C) we
1418 of rat nNOS (SC-648), while the section in (D) was incubated in a rabbi
bars, A–C, 15 lm; 1D, 30 lm.& Young, 1988) or type 1 and type 2 (Sagar, 1990)
NADPH-diaphorase positive amacrine cell types in the
rabbit, and to the NDa and NDb NADPH-diaphorase
positive amacrine cell types in the guinea pig (Cobcroft,
Vaccaro, & Mitrofanis, 1989).
In contrast, when the primary antiserum directed
against porcine cerebellar nNOS (Mayer et al., 1990)
was used there was much more extensive labeling. With
this antiserum there was nNOS-LI in photoreceptor
ellipsoids, many amacrine cell somata, near the outer
limiting membrane, in many boutons and processes in
the IPL, and in numerous somata in the GCL
(Fig. 1D). It is possible that the diﬀerences in labeling
seen with these two antisera indicate that they may be
recognizing alternate expressions of nNOS such as the
natural variants of nNOS produced in the central ner-
vous system by selective alternative splicing of the nNOS
gene (Iwasaki et al., 1999).
3.2. Ultrastructural localization of nNOS-LI
No signiﬁcant labeling was seen in the bipolar or hor-
izontal cell somata at the ultrastructural level, although
patches of nNOS-LI have been associated witht three amacrine cell types (vertical arrows, type 1 in A; type 2 in B; and
the GCL (vertical arrowheads in D), the ellipsoids of photoreceptors
acrine cell somata had strong nNOS-LI (vertical arrow in D), while
re labeled using a rabbit primary antiserum against amino acids 1400–
t antiserum against porcine cerebellar nNOS (Mayer et al., 1990). Scale
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nNOS-LI in the tips of some bipolar and horizontal cell
processes that are postsynaptic to photoreceptor ribbon
synapses and at basal junctions between photoreceptors
(Haverkamp & Eldred, 1998). The lack of stronger
somatic labeling in horizontal and bipolar cells at the
ultrastructural level is probably due to the decreased
antigenicity caused by the ﬁxation protocol used for
electron versus light microscopy.
NeuronalNOS-LIwas found associatedwith the outer
membranes of the nucleus and the endoplasmic reticulum,
and as diﬀuse ﬂocculent immunoreactivity in the cyto-
plasm in some amacrine cell somata (Fig. 2A). In the
IPL many amacrine cell processes had strong nNOS-LI.
These processes could be identiﬁed as amacrine cell pro-
cesses by their lack of synaptic ribbons and the presence
of synaptic vesicles at conventional synapses. In some la-
beled amacrine cells, the electron-dense reaction product
diﬀusely ﬁlled the entire cell process (Fig. 2B).
Neuronal NOS-LI was also present in the ellipsoid in
the inner segments of rods (not shown) or the accessory
elements of the double cones (Fig. 3A 0) in some atypical
mitochondria that were interspersed among the conven-
tional mitochondria composing the ellipsoid. These atyp-
ical mitochondria were characterized by having poorly
developed cristae. The adjacent conventional mitochon-
dria in the ellipsoid showed no such increases in electron
density. In some presumptive amacrine cell processes,
there were also conventional mitochondria with nNOS-
LI in their intermembrane space (Fig. 3B 0). These labeled
mitochondria were distinct from those in the photorecep-
tor ellipsoids, in that in the photoreceptors there was
granular immunoreactivity in the matrix and they had
poorly developed cristae. In contrast, the labeled mito-
chondria in the amacrine cell proﬁles had nNOS-LI
which was more selectively conﬁned to the intermem-
brane space and they had well deﬁned cristae.
In some amacrine cell boutons in the IPL, the nNOS-
LI was selectively associated with the presynaptic spe-Fig. 2. (A) In the INL in turtle, nNOS-LI was found associated with the nucl
and as diﬀuse ﬂocculent nNOS-LI (white arrowhead) in the cytoplasm in som
diﬀusely ﬁlled some amacrine cell processes (white arrows). Scale bars, 1 lmcializations (Fig. 3C 0), with relatively little cytoplasmic
nNOS-LI. Some amacrine cells made more than one
conventional synaptic contact in a given bouton, only
some of which had nNOS-LI at their presynaptic spe-
cialization (Fig. 3C 0). It was likely that this nNOS-LI
was truly presynaptic because in more weakly labeled
preparations, it was possible to clearly see the nNOS-
LI was associated with clusters of synaptic vesicles and
that there were the conventional parallel membrane
specializations.
Selective subcellular localization of nNOS-LI was
also seen in some bipolar cell axon terminals
(Fig. 3D 0). In these bipolar terminals, the immunoreac-
tivity was present in a small cytoplasmic region associat-
ed with the plasma membrane a micron or less from the
ribbon synapse. In this specialized region, the two plas-
ma membranes ran parallel to one another forming a
uniform extracellular space. Although the parallel mem-
branes and the consistent extracellular space suggested
the existence of a synapse, the density of the nNOS-LI
in this region obscured any clusters of synaptic vesicles.
At the ultrastructural level, very few somata in the
GCL contained nNOS-LI and the labeling was much
weaker than found in amacrine cell somata. Most of
the nNOS-LI was associated with the endoplasmic retic-
ulum or was located diﬀusely in the cytoplasm. The exis-
tence of nNOS-LI in some axons in the ganglion cell
axon layer supported that some of these labeled somata
were ganglion cells. Neuronal NOS-LI was present in
mitochondria in Mu¨ller cells near the outer limiting
membrane and in patches in Mu¨ller processes in the
IPL. There was also some nNOS-LI associated with
Mu¨ller cell villi surrounding the photoreceptors.
3.3. Nitric oxide imaging
The selective localization of nNOS-LI at speciﬁc syn-
apses or in select mitochondria seems at odds with it
being a freely diﬀusible gas which has been suggestedear membrane (black arrow), the endoplasmic reticulum (white arrow),
e amacrine cell somata. (B) In the IPL, electron-dense reaction product
.
Fig. 3. (A 0) In some turtle photoreceptor ellipsoids (E) there were typical mitochondria (white arrow) and also some atypical mitochondria (black
arrows) in the ellipsoids of rods and accessory elements of double cones (A) have nNOS-LI which increased their overall electron density and was
most apparent in the intermembrane space. There was also some nNOS-LI associated with their outer segments. (B 0) Some presumptive amacrine cell
processes had mitochondria (M) with nNOS-LI. (C 0) In some amacrine cell synaptic terminals, the nNOS-LI was only associated with the presynaptic
region of conventional synapses (arrow in C 0). Some amacrine cell synaptic terminals made more than one conventional synaptic contact, only some
of which had nNOS-LI at their presynaptic specialization (C 0, arrow, with nNOS-LI; arrowhead, without nNOS-LI). (D 0) In some bipolar cell
terminals (B), there was a patch of cytoplasmic nNOS-LI (arrow) associated with the plasma membrane some distance from the ribbon synapse
(arrowhead). Scale bars: A 0 and B 0, 0.5 lm; C 0 and D 0, 0.25 lm.
W.D. Eldred, T.A. Blute / Vision Research 45 (2005) 3469–3486 3475to potentially diﬀuse 100s of microns (Wood & Gart-
hwaite, 1994). Furthermore, although the NOS immu-
nocytochemistry suggested that there were a wide
variety of potential sources for NO production, ques-
tions remained as to which sources were active under
what circumstances and how the NO spread in retina.
Kojima et al. (1998a, 1998b) developed the NO spe-
ciﬁc ﬂuorescent probe diaminoﬂuorescein (DAF). When
DAF is nitrosated by reactive nitrogen oxides such as
N2O3 at one of its amino groups the reaction leads to
the formation of the triazole DAF-2T. DAF is relatively
non-ﬂuorescent until it binds the NO oxidation product
and forms DAF-2T which increases the quantum eﬃ-
ciency of its ﬂuorescence by 180-fold (Kojima et al.,
1998b). When this dye is used to label retinal slices, it
is possible to localize NO production within speciﬁc ret-
inal cell types.
3.4. Speciﬁcity controls for imaging NO
In cell-free solutions, the ﬂuorescence increase pro-
duced by the combination of DAF and NO donor showsa linear relationship between the concentration of NO
donor in the solution and the rate of increase of NO
(Blute et al., 2000; Nagata, Momose, & Ishida, 1999).
This occurs because in a cell-free solution, the NO donor
is continuously liberating NO. Thus, the increase in NO-
IF over time represents an integral of the NO produc-
tion. These results suggested that the rate of increase
in ﬂuorescence can be correlated with the relative con-
centration of NO.
In slices loaded with DAF and illuminated with
490 nm light, there was a slight ﬂuorescence throughout
the unstimulated control retinas which allowed the visu-
alization of some labeled somata and the plexiform lay-
ers (Fig. 4A). These weakly labeled somata are probably
a reﬂection of the endogenous levels of NO in control
tissue. When illuminated over time, there was a small
steady decrease in this baseline ﬂuorescence probably
due to bleaching (Fig. 4B). This indicates that the light
stimulation itself does not activate DAF. The addition
of the NO-donor, SNAP, caused an immediate overall
increase in ﬂuorescence throughout the slice which con-
ﬁrmed that all of the cells were loaded with DAF and
Fig. 4. Eﬀects of NO-donor on a turtle retinal slice loaded with DAF.
(A) In these contrast reversed images of a retinal slice loaded with
DAF and illuminated with 488 nm light, there was some faint NO-IF
apparent in the ONL and INL. (B) After 180 s of illumination there
was only a slightly perceptible decrease in the levels of NO-IF which
indicates that DAF is not activated by light alone. (C) Stimulation with
100 lM of the NO-donor SNAP at 180 s caused a dramatic and
uniform increase in NO-IF throughout the slice by 240 s. This broad
increase in NO-IF indicated that the entire slice was uniformly loaded
with DAF. Scale bar, 20 lm
Fig. 5. Eﬀects of NOS inhibitor on the levels of NMDA stimulated
increases in NO-IF. (A) A contrast reversed image of a DAF loaded
retinal slice that was pre-incubated with the NOS inhibitor 100 lM L-
NMMA. In the absence of stimulation there was some faint NO-IF in
some somata in the INL and GCL. (B) Even 400 s after stimulation
with 250 lM NMDA there was still no increase in NO-IF which
indicates that NMDA stimulated increases in NO-IF require the
presence of enzymatically active NOS. Notice the decrease in endog-
enous NO-IF after 400 s of illumination. Scale bar, 20 lm.
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zation of the DAF (Fig. 4C). Addition of depleted
SNAP resulted in no such change in ﬂuorescence.
All NMDA-stimulated increases in ﬂuorescence were
eliminated by inhibiting NOS. Slices that were pre-incu-
bated and imaged in the presence of the potent irrevers-
ible NOS inhibitor, 100 lM L-NMMA, exhibited no
increases in ﬂuorescence in response to 250 lM NMDA
(Figs. 5A and B). This control is consistent with the ﬂuo-
rescence being due to the production of NO by NOS.
Adding exogenous arginine to the loading Ringer en-
hanced the increase in ﬂuorescence in response to
NMDA stimulation, but did not evoke an increase in
NO-IF by itself or alter the cell types responding to
NMDA. A similar arginine-stimulated enhancement of
DAF ﬂuorescence is reported in several previous studies
(Kojima et al., 1998a; Nakatsubo et al., 1998).In total, these control experiments conﬁrmed that the
increased ﬂuorescence we saw in response to NMDA
stimulation was correlated with increased NO produc-
tion resulting from NMDA receptor activation. With
the results of these controls in mind, we use the term
NO-IF.
3.5. Anatomical localization of NO production
In the turtle retina, at the light microscopic level,
nNOS-LI is present in three amacrine cell types and
their processes in the IPL, in ganglion cell somata, in
photoreceptor inner segments, and in Mu¨ller cell pro-
cesses near the outer limiting membrane (Blute et al.,
1997). Moreover, detailed ultrastructural investigations
ﬁnd nNOS-LI in photoreceptors, horizontal cells, and
bipolar cells in the outer retina (Cao & Eldred, 2001;
Haverkamp & Eldred, 1998). NMDA stimulation is able
to increase NO-IF in all of these locations in select cells
throughout the retina (Blute et al., 2000). This NMDA-
stimulated increase in NO production is consistent with
the previous results of Blute et al. (1998) showing that
NMDA can increase levels of cGMP by activating
NOS in turtle retina.
All of the images in Fig. 6 were captured real-time
from live slices of turtle retina. In some but not all pho-
toreceptors, NMDA-stimulated NO-IF increased
throughout the entire inner segment, soma and synaptic
terminal (Fig. 6A). The increased NO-IF was ﬁrst ob-
served in the ellipsoid, and the strongest overall increas-
es in NO-IF in photoreceptors were in the ellipsoid.
Within 30 s, lower levels of increased NO-IF were seen
in photoreceptor somata and synaptic terminals. The
presence of oil droplets indicated that at least some of
these photoreceptors were cones. The high levels of
NO-IF seen in the ellipsoid, agree with the immunocyto-
chemical and histochemical localization of NOS in this
region (Blute et al., 1997; Cao & Eldred, 2001; Koch,
Lambrecht, Haberecht, Redburn, & Schmidt, 1994) in
many species. It is likely that the NO-IF seen in photo-
Fig. 6. Contrast-reversed digital images of NMDA (100 lM) stimulated increases in NO-IF that was imaged real-time in living slices of turtle retina.
(A) Strong NO-IF was concentrated in the ellipsoid region (horizontal arrows) of the inner segment of many photoreceptors. Lower levels of NO-IF
were present in the somata and synaptic terminals of these cells (arrowhead). Diﬀuse weak NO-IF was also present at the OLM and OPL. (B) NO-IF
was present in horizontal cell somata (black arrow) and their dendritic processes (white arrows) in the OPL. (C) Bipolar cell somata (both normally
placed, vertical arrows; and displaced, horizontal arrow) and some of their processes in the OPL (arrowhead) exhibited NO-IF in response to
NMDA. Diﬀuse NO-IF was also present in the ONL in the Landolts clubs of bipolar cells and in the apical processes of Mu¨ller cells (asterisk) near
the OLM. (D) Amacrine cell soma (vertical arrow) with strong NO-IF in its soma and primary process. A soma in the GCL had strong NO-IF
(horizontal arrow) that spread from the soma, while isolated boutons had smaller increases of NO-IF (horizontal arrowheads) that were more
contained. (E) Amacrine cells (horizontal arrows) with strong NO-IF in their somata and in their process with many labeled boutons (arrowheads).
Note that the NO-IF was quite strong and concentrated in the boutons. (F) Amacrine cell with strong NO-IF in its soma and primary processes that
closely resembled a type 3 nNOS amacrine cell (vertical arrow). Although this cell type is the least common amacrine cell with nNOS-LI, they were
frequently observed with NO-IF in response to NMDA. This suggested that these cells had a high density of NMDA receptors. (G) Amacrine cell
(horizontal arrow) with strong NO-IF in its soma, and lower levels of NO-IF in its processes in the IPL. This cell does not clearly resemble previously
described amacrine cell types with nNOS-LI. Several ganglion cell somata had strong NO-IF (arrowheads) which diﬀused into the surrounding GCL.
(H) Mu¨ller cell with NO-IF in its soma (horizontal arrow) and processes. The NO-IF in Mu¨ller cells often began in small swellings on their processes
(arrowheads) and spread up to ﬁll their entire soma. (I) In response to NMDA, many amacrine cell processes and their associated boutons (vertical
arrowheads) demonstrated NO-IF. The levels of NO-IF in the processes interconnecting the boutons were lower than in the boutons. In this slice,
several somata in the GCL had very high levels of NO-IF that diﬀused to ﬂood the entire GCL (asterisk). (J) In the region near the GCL and ILM,
there were many somata (vertical arrow) and Mu¨ller cell processes (horizontal arrow) with associated swellings (arrowheads) with elevated NO-IF.
Scale bars, 20 lm.
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NMDA receptor subunits that have been previously
localized presynaptically within both rod and cone pho-
toreceptor terminals (Fletcher, Hack, Brandstatter, &
Wa¨ssle, 2000).
The previous ultrastructural localization of nNOS-LI
at speciﬁc contacts in the OPL (Haverkamp & Eldred,
1998) is consistent with the strong NMDA-stimulated
increase in NO-IF seen in the OPL. Horizontal
(Fig. 6B) and bipolar cell (Fig. 6C) somata with NO-
IF were observed only occasionally, but ﬂuorescent pro-
cesses in the OPL were common (Figs. 6B and C). Pre-
vious physiological studies support NO production by
horizontal cells in the turtle retina (Miyachi et al.,
1990) and in the hybrid bass retina (McMahon & Pon-omareva, 1996). Although NMDA receptors have not
been localized on turtle horizontal or bipolar cells, it is
possible that the NMDA stimulated NO-IF in these cells
may also relate to the NMDA receptors localized on
both rod and cone photoreceptor terminals (Fletcher
et al., 2000). If NMDA activates these receptors to in-
crease glutamate release from photoreceptors, this gluta-
mate could activate the kainate receptors which have
been shown to activate bipolar and horizontal cells
(Marc, 1999).
A prominent feature of retinal nNOS-LI would be the
numerous labeled amacrine cell somata (Blute et al.,
1997). Consistent with the strong nNOS-LI observed
in multiple amacrine cell types, NMDA dramatically in-
creased NO-IF in a wide variety of amacrine cells (Figs.
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ed several diﬀerent forms of NO-IF. Many amacrine
cells had increased NO-IF that was conﬁned to their
somata (not shown), while in other cases the NO-IF in-
creased in both their somata and processes (Figs. 6D–
G). Some of the labeled amacrine cells had swellings
on their processes that resembled synaptic boutons
(Fig. 6E), while others did not (Figs. 6F and G). When
present, the active boutons often had more intense NO-
IF than the rest of the adjacent process, although the
NO-IF in boutons was still often weaker than seen in
the somata of the same cells. There were also activated
processes in the IPL that were not directly associated
with labeled somata (Fig. 6I). These isolated processes
with NO-IF usually had boutons. In addition, there
were isolated boutons with high NO-IF found in the
IPL that were not associated with any labeled processes
(Fig. 6D).
Immunocytochemistry indicates that there is nNOS
conﬁned within many somata in the GCL in turtle
(Blute et al., 1997). In response to NMDA, some somata
in the GCL exhibited some of the strongest increases in
NO-IF seen in the retina (Figs. 6D, G, and I). Interest-
ingly, although the NO-IF appeared to diﬀuse out of
these somata in the GCL, it did not ﬁll the processes
of these cells as it did in many of the adjacent amacrine
cells.
Previous studies have described the presence of
nNOS in Mu¨ller cells, although they usually have much
less nNOS-LI than other retinal cell types (Kurenni
et al., 1995; Liepe, Stone, Koistinaho, & Copenhagen,
1994). In turtle, there is little apparent nNOS-LI in Mu¨l-
ler cells (Blute et al., 1997). Considerable NO-IF ap-
peared in Mu¨ller cells after several minutes of NMDA
stimulation. These increases in NO-IF in Mu¨ller cells
would often begin in their processes near the outer or in-
ner limiting membranes and spread centrally to their
soma (Fig. 6H). In the GCL and ganglion cell axon layer
(GCAL), Mu¨ller cell end feet had small varicosities (less
than 5 lm in diameter) with strong NO-IF (Fig. 6J). It is
likely that the NMDA stimulated increases in NO-IF in
Mu¨ller cells may relate to the NMDA receptors which
have been shown to be present on Mu¨ller cells in human
retina (Puro, Yuan, & Sucher, 1996) and the nNOS-LI
which has been reported in Mu¨ller cells in turtle retina
(Cao & Eldred, 2001).
In conclusion, every retinal cell type, but not every
cell of a given type can show increases in NO-IF. It is
interesting that all of the cells of a speciﬁc anatomical
type, i.e., H1 horizontal cells, do not show a uniform re-
sponse in that only some show increased NO-IF in re-
sponse to a given stimulus. This raises the possibility
that there may be neurochemical diﬀerences between
anatomically similar retinal cells in that only some
may utilize the NO/cGMP signaling pathway. This idea
of selective localization is supported by the localizationof nNOS-LI in only some rod bipolar cell dendrites in
rat retina (Haverkamp & Eldred, 1998).
These NO imaging results conﬁrmed previous light
and electron microscopic immunocytochemical studies
(Blute et al., 1997; Cao & Eldred, 2001; Haverkamp &
Eldred, 1998; Liepe et al., 1994) which demonstrated
NOS in every cell type in the retina and at speciﬁc syn-
aptic contacts.
3.6. Kinetics of NO-IF production in response to blocking
GABAergic inhibition or stimulation with NMDA
In response to pharmacological stimulation, somatic
increases in NO-IF all followed a similar general time-
course, when intensity levels were plotted against time
(Fig. 7). During the rising phase, the intensity of NO-
IF increased exponentially from baseline levels to a tran-
sient peak, which was immediately followed by a slower
exponential decrease. For each of these pharmacological
stimuli the diﬀerent sources of NO-IF had characteristic
time-courses. Though some ganglion cells diﬀered in
their peak responses, their response kinetics were simi-
lar. The same kinetic similarities were seen for other
sources such as amacrine cell somata or boutons. Inter-
estingly, ganglion cells showed a more sharply peaked
response to 100 lM NMDA, while the boutons showed
a more sharply peaked response to picrotoxin/bicucul-
line. However, amacrine cell somata had less steep rising
and falling phases than did ganglion cells. Boutons in
the IPL displayed less stereotypic responses and more
variability, with a slower, more linear (less exponential)
rising phase, a lower relative peak, and often a slower
decay. In some cases, the increases in NO-IF in some
boutons and ganglion cells had shorter onset latency
in response to blockade of GABAergic inhibition than
those seen in response to NMDA.
3.7. Quantiﬁcation of the apparent diﬀusion of NO-IF
In some cells, the NO-IF spread well beyond their cell
boundaries (Figs. 6G and I), as would be predicted by
the previous models of NO diﬀusion (Wood & Garthwa-
ite, 1994). However, in many cells, even in cells with very
high levels of NO-IF, there was relatively little spread of
NO-IF beyond the cell boundary (Fig. 6E) and the NO-
IF did not spread more than 10 lm from the source. In
contrast, in some other cells, particularly somata in the
GCL, there was considerable spread beyond the site of
production (Figs. 6G and I). These diﬀerences in spread
were often seen between two diﬀerent cell types within
the same retinal slice, which would support there being
a cell speciﬁc control over the spread of NO.
It is possible to use small NO-selective electrodes to
measure the NO levels near a single retinal neuron.
Fig. 8A shows the NO-electrode placed near a soma in
the GCL, while Fig. 8B shows the change in the concen-
Fig. 7. Quantitative analysis of increases in NO-IF in turtle in
response to 100 lM NMDA (A) or a combination of 50 lM
bicuculline and 50 lM picrotoxin (B). In all cases the drugs were
added at time T = 0. Each of the curves represents the levels of NO-IF
in relation to the unstimulated baseline ﬂuorescence over time for a
chosen region of interest of single example of the indicated structure.
The overall levels of increases in NO-IF were greater for NMDA than
for the combination of GABAergic antagonists. Each of the diﬀerent
cellular sources had characteristic time-courses for each pharmacolog-
ical treatment even if there were diﬀerences in the overall intensity of
the responses, i.e., ganglion cells (A) had similar kinetics. In some cases
the production of NO-IF in boutons was much quicker in response to
GABAergic antagonists than NMDA.
W.D. Eldred, T.A. Blute / Vision Research 45 (2005) 3469–3486 3479tration of NO in response to stimulation with 100 lM
NMDA. In this case the NO concentration rose from
the preexisting background concentration of 96 to
174 nM which indicates that DAF is able to easily de-
tect changes in nanomolar levels of NO. Given that there
may be some retention of NO within the soma, it is pos-
sible that the intracellular levels of NO were higher than
174 nM. Such quantitative measurements of NO levels
can then be used to quantify the NO levels within a given
digital image because there is a linear relationship be-
tween the NO concentration and NO-IF (Blute et al.,
2000). Surprisingly, even if an intracellular NO concen-tration of 174 nM is assumed, there are NO concentra-
tions below 10 nM within 10–20 lm away from
relatively strong sources of NO production. This further
supports a rather limited spread of NO in some cases.
3.8. Aldehyde ﬁxation of DAF
Previous studies have shown that aldehydes can be
used to stabilize activated DAF in tissues (Kasim
et al., 2001; Sugimoto et al., 2000). We reasoned that
aldehyde ﬁxation could stabilize the activated DAF to
visualize NO produced in the dark using conventional
confocal microscopy. However, this DAF ﬁxation pro-
tocol has not been applied previously to examine retinal
slices. To validate this method, control ﬁxation experi-
ments were performed to show that the ﬁxation did
not non-speciﬁcally increase NO-IF and that ﬁxation
did not alter the localization of NO-IF.
One particular advantage of this method is that if the
DAF is activated before it is ﬁxed with paraformalde-
hyde, it will remain activated after ﬁxation. Fig. 9A
shows the NO-IF in a living turtle retinal slice that has
been stimulated with 20 lM picrotoxin. The NO-IF
was present in what appears to a bipolar cell terminal.
Fig. 9B shows a comparable slice that was also stimu-
lated with picrotoxin before being ﬁxed with parafor-
maldehyde. The labeling in this ﬁxed slice closely
resembled that seen in the live slice. The ﬁxation also
provided several other beneﬁcial results. There was an
apparent increase in NO-IF in response to aldehyde ﬁx-
ation as has been described previously (Sugimoto et al.,
2000). This increase in NO-IF was often so substantial
as to require a decrease in the gain of the CCD camera
to successfully capture the image. The ﬁxation and sub-
sequent increase in NO-IF also made it much easier to
use confocal microscopy to obtain high resolution imag-
es. Finally, ﬁxation seems to optically clear the tissue
which makes it easier to obtain confocal images from
deeper portions of thick retinal slices. Fig. 10 shows a
three dimensional rendering of NO-IF in a retinal slice
that was stimulated with 660 nm ﬂashing light before
being ﬁxed with aldehydes.
To conﬁrm that ﬁxation did not non-speciﬁcally in-
crease NO-IF and that ﬁxation did not alter the localiza-
tion of NO-IF, retinal slices were stimulated with 50 lM
nicotine and then imaged before and following ﬁxation.
In Fig. 11 the red color indicates theNO-IF that was pres-
ent following 10 min of stimulation before ﬁxation. The
green color indicates the NO-IF that was present follow-
ing 30 min of paraformaldehyde ﬁxation. The yellow col-
or indicates the NO-IF that was present before and after
ﬁxation. There is virtually no pure green in the image indi-
cating that ﬁxation did not induce or create any NO-IF
that was not there prior to ﬁxation. There is however
extensive red over the photoreceptorswhich indicates that
much of the NO-IF in the photoreceptors was lost during
Fig. 8. (A) Image of a NO selective microelectrode (M) with its sensor tip (arrow) placed adjacent to a ganglion cell with NO-IF in turtle. (B) Time-
course of the increase in NO concentration measured with this microprobe. Before the application of NMDA the existing NO concentration in the
region of this somata was 96 nM, while after the NMDA stimulation the concentration rose to 174 nM. Scale bar, 20 lm.
Fig. 9. (A) Image of picrotoxin stimulated NO-IF in a slice of turtle retina. (B) A lower magniﬁcation image of NO-IF in a slice that was ﬁxed with
paraformaldehyde following stimulation with picrotoxin. The NO-IF seen in both the living and tissue is quite comparable. The circles in both A and
B indicate comparable dendritic arborizations. Scale bars: A, 10 lm; B, 20 lm.
Fig. 10. This is an image of NO-IF in a retinal slice made from a
collapsed confocal stack that has been three-dimensionally rendered
using the three-dimensional rendering software on a Zeiss
LSM510NLO two-photon confocal microscope. This slice was stim-
ulated using a 660-nm ﬂashing light before being ﬁxed with aldehydes.
Note the excellent anatomical detail that is available of amacrine cells
arborizations (A, horizontal arrow) and individual synaptic boutons in
the IPL and horizontal cell arborizations in the OPL (H, vertical
arrow). Scale bar, 20 lm.
Fig. 11. The red indicates the NO-IF that was present in salamander
following 10 min of stimulation with 50 lm nicotine before ﬁxation.
The green indicates the NO-IF that was present following 30 min of
paraformaldehyde ﬁxation. The yellow indicates the NO-IF that was
present before and after ﬁxation. There is virtually no pure green in the
image indicating that ﬁxation did not induce or create any NO-IF that
was not there prior to ﬁxation. The red over the photoreceptors
indicates that much of the NO-IF in the photoreceptors was lost
during ﬁxation. Scale bar, 20 lm.
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Fig. 12. Imaging of NO-IF in response to diﬀerent lighting conditions
in salamander retina. (A 0) In the dark, there was strong NO-IF in
many horizontal cells (H), some photoreceptors (P), and some
amacrine cell somata (A) in the INL. There may be a potential loss
of NO-IF from photoreceptors so this labeling may be underrepre-
sented. (B 0) In steady light, there was still NO-IF in some photore-
ceptors and horizontal cells, but there were also some somata in the
GCL and many amacrine cell somata (A) in the INL, and boutons in
the IPL had strong NO-IF. (C 0) In ﬂashing light there was still strong
NO-IF in the same sources seen with steady light, but there was strong
NO-IF in more amacrine cell somata and their processes, in
presumptive ganglion cell somata (G), and in numerous boutons in
the IPL. Scale bars, 20 lm.
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ing element that paraformaldehyde can cross-link with
DAF to retain activated DAF within the photoreceptors.
The increasedNO-IF in horizontal cells may be related to
the uncoupling eﬀects of cholinergic agonists that have
been reported in horizontal cells in mudpuppy retina
(Myhr &McReynolds, 1996). Thus there is no indication
that ﬁxation produces any artifactual production of NO-
IF orDAFactivation and that in some cell types there can
be a decrease in NO-IF in response to ﬁxation. This alde-
hyde ﬁxation method is thus ideal for studying light stim-
ulated NO production in retina.
3.9. Light stimulated NO-IF
The ability to use paraformaldehyde ﬁxation to stabi-
lize NO-IF allows the analysis of NO production in the
dark and in response to various light stimulation proto-
cols. It is also possible to use a multi-photon confocal
microscope to image NO-IF real-time using an 810-nm
excitation wavelength without activating or bleaching
the photoreceptors (Eldred, personal communication).
However, this method is expensive and logistically chal-
lenging. It is much simpler to use aldehyde ﬁxed DAF. If
the dark adapted retinal slices are made in the dark
using infrared imaging equipment, then loaded with
DAF and washed in the dark, it is possible to image
the levels of NO-IF that are present in the dark. In sal-
amander retina in the dark, there was strong NO-IF in
many horizontal cells, some somata in the INL, and
some photoreceptors (Fig. 12A 0). As described above,
there may be a potential loss of NO-IF from photore-
ceptors so this photoreceptor labeling may be underrep-
resented. We examined the light-driven NO-IF in dark
adapted retinal slices. In steady light, there was still
NO-IF in some photoreceptors and horizontal cells,
but there were also some somata in the GCL, many
more somata in the INL, and many boutons in the
IPL with strong NO-IF (Fig. 12B 0). In ﬂashing light
there was still strong NO-IF in the same sources seen
with steady light, but there was much stronger NO-IF
in more amacrine cell somata, in somata in the GCL,
and in processes and numerous boutons in the IPL
(Fig. 12C 0). These results indicate that NO is part of a
light activated signaling pathway.
It is interesting that the production of NO-IF in hor-
izontal cells is increased by light in that photoreceptor
transmitter release is reduced in the light which should
hyperpolarize the horizontal cells. This result suggests
that activation of NOS is not purely by inﬂux of extra-
cellular calcium and that other sources of calcium may
be involved. For instance, it is possible that metabotro-
pic receptors, such as the mGluR5 receptors reported to
be present on horizontal cells (Hartveit, Brandstatter,
Enz, & Wassle, 1995) may be activating release of calci-
um from intracellular stores to increase NO-IF. It is alsoimportant to point out that the dark adapted retinas had
been dark adapted for several hours and the increased
levels of NO-IF may be a reﬂection of this long
Fig. 14. Colocalization of NO-IF and cGMP-LI in a salamander
retinal slice stimulated with 50 lM nicotine. The NO-IF is green and
the cGMP-LI is red. The horizontal cells on the left and right (vertical
arrows) had both strong NO-IF and cGMP-LI, while the center
horizontal cell (horizontal arrow) had primarily NO-IF. Note the
apparent lack of NO-IF in the dendrites of these horizontal cells. Scale
bar, 20 lm.
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ﬂashing light, versus steady light or darkness, which
indicates the transition between light to dark may be
the strongest activator of NO production.
3.10. Colocalization of nNOS-LI with NO-IF
The ability to ﬁx NO-IF with paraformaldehyde al-
lows imaging of NO-IF to be combined with convention-
al nNOS immunocytochemistry. This can serve as a
control to conﬁrm that increases in NO-IF are due to
the activation of NOS; and by using isoform speciﬁc
NOS antisera it is possible to associate these increases
with particular isoforms of NOS. Moreover, it is possible
to determine which of a population of NOS containing
cells can be selectively activated by a particular stimulus.
Fig. 13 shows NO-IF in retinal slices that have been
stimulated with 50 lM nicotine and then immunocyto-
chemically labeled using an antiserum directed against
nNOS. In these images the NO-IF is green, the nNOS-
LI is red, and the yellow indicates that it was nNOS that
was producing the NO-IF. Interestingly, the yellow dou-Fig. 13. Colocalization of NO-IF and nNOS-LI in salamander retinal
slices stimulated with 50 lM nicotine. In these images the NO-IF is
green, the nNOS-LI is red, and yellow indicates that it was nNOS that
was producing the NO-IF. The yellow double labeling indicates that
nicotine primarily activates nNOS in somata in the INL and GCL (A
and B, horizontal arrows). (A) In some horizontal cells in the INL and
in some somata in the GCL, the nNOS is not activated by nicotine
(vertical arrows). In some somata in the INL there is NO-IF but no
nNOS-LI, which potentially indicates the activation of other isoforms
of NOS than nNOS. Scale bars, 20 lm.ble labeling indicated that nicotine primarily activated
nNOS in the somata of amacrine cells and in not their
processes in the IPL. In contrast, nicotine increased lev-
els of NO-IF in both the somata and some primary pro-
cesses in horizontal cells (Fig. 13B). Finally, these
images indicate that nicotine did not activate the nNOS
in all of the cells that contained it (red somata in
Fig. 13A) and further that nicotine increased NO-IF in
cells which did not contain nNOS-LI (green somata in
Fig. 13B). This suggests that another NOS isoform, per-
haps eNOS was also activated by nicotine.
3.11. Imaging NO-IF and the downstream production of
cGMP
The use of paraformaldehyde ﬁxation also allows the
simultaneous visualization of the cells which produce
NO-IF and the cells in which soluble guanylate cyclase
is activated to produce the synthesis of cGMP. When
retinal slices were stimulated with 50 lM nicotine and
imaged using a combination of NO-IF and cGMP
immunocytochemistry, it was evident that in turtle reti-
na some horizontal cells can have primarily have NO-IF
alone (Fig. 14, green somata with horizontal arrow),
while other horizontal cells can show an increase in
NO-IF and also show a cell autonomous increase in
cGMP-LI (Fig. 14, vertical arrowheads). These results
indicate that the entire NO/cGMP signaling pathway
can be functionally demonstrated using a combination
of imaging of NO-IF and cGMP immunocytochemistry.4. Discussion
4.1. Correlation of the localization of nNOS-LI and
NO-IF
The light and electron microscopic localization of
nNOS-LI indicated that every cell type in the retina
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localization was surprisingly speciﬁc in that the nNOS-
LI was found at speciﬁc synapses or it was associated
with certain cellular organelles. This relative speciﬁcity
is seemingly at odds with the suggestions that NO can
diﬀuse for 100s of microns (Wood & Garthwaite,
1994). The imaging of NO-IF strongly supports the
broad immunocytochemical localization of nNOS-LI
in that it was possible to see NO-IF in every location
where there was nNOS-LI. In addition, the selective
localization of nNOS-LI was also reﬂected in the speci-
ﬁcity of NO-IF, in that the NO-IF could be seen within
photoreceptor ellipsoids or individual synaptic boutons.
This close anatomical correlation also conﬁrms that
NO-IF truly represents NO being synthesized by NOS.
However, the fact that some of the NO-IF does not
colocalize with nNOS-LI suggests that other NOS iso-
forms, most likely eNOS are also involved. Additional
double labeling studies of eNOS-LI and NO-IF should
clarify this issue.
4.2. Diﬀusion of NO from speciﬁc cellular sources
Previous reports (Wood&Garthwaite, 1994) have sug-
gested that NO is freely diﬀusible. However, the present
imaging of NO-IF would suggest that this is not always
the case. It appeared that for many sources there was rel-
atively little diﬀusion, while for other sources there was
considerable diﬀusion. There were also diﬀerences in the
extent of intracellular diﬀusion. For instance, in some
amacrine cells theNO-IF completely ﬁlled the cell, includ-
ing its processes, with little extracellular diﬀusion. It is
likely that these results indicate that NO can spreadmuch
less from some sources than others. Since all of the cells
containDAF, if the NO diﬀuses out of one cell it will acti-
vate the DAF in the contiguous cells (Figs. 6G and I) and
thus be detected. The fact that both apparent diﬀusion
and lack of diﬀusion was seen in diﬀerent cells in the same
slice (Fig. 6G) would strongly support that a lack of diﬀu-
sion was not an artifact of the DAF imaging method.
NO-IF does not support free diﬀusion models of NO
signaling. It is also possible to functionally show a lack
of spread of NO in retina. When a retina is stimulated
with a NO donor it is possible to activate all of the
sGC to synthesize cGMP (Blute et al., 1998). If NO
was freely diﬀusible then the pattern of cGMP produc-
tion should resemble that seen with a broadly applied
NO donor. This was not the case however. For example,
stimulation with nicotine strongly activated NO and
cGMP production in horizontal cells (Fig. 13), but no
increases in cGMP were seen in closely adjacent bipolar
and amacrine cells which have been shown to contain
NO activatible sGC in previous studies (Blute et al.,
1998). Clearly, the NO does not diﬀuse the few microns
from the horizontal cells to the adjacent bipolar and
amacrine cells containing sGC.There was also relatively little spread of NO-IF out
from individual boutons, although it is likely there would
still be enough spread to move the 1–3 lm from one syn-
apse to an adjacent bouton. It is interesting to note that
the NO-IF in some boutons did not appear to spread
through the cell processes interconnecting them. In con-
trast, many somata in the GCL showed considerable
spread of NO-IF. However, even in the case of diﬀusion
out of these somata in the GCL, there was no apparent
diﬀusion of NO-IF into the processes of these cells. This
suggests that in addition to mechanisms which retain NO
within the entire cell, there are also mechanisms to con-
trol the movement of NO within a single cell. The fact
that DAF has been calculated to have only a 9.6%
binding eﬃciency (Nakatsubo et al., 1998) suggests that
over 90% of the NO would be free to diﬀuse as it normal-
ly would. This again supports that if NO was spreading,
we could image its spread.
There are several possibilities why the NO would not
be more freely diﬀusible. One likely explanation is that
the NO is bound to thiols such as glutathione to form
nitrosothiols such as glutathione (Hogg, 2002; Singh,
Hogg, Joseph, & Kalyanaraman, 1996; Upchurch,
Welch, & Loscalzo, 1995). Very high levels of glutathi-
one have been localized in speciﬁc retinal cell types such
as Mu¨ller cells and horizontal cells (Pow & Crook,
1995). Such a functional cellular sink for NO has been
suggested to be involved in shaping low level NO signals
(Griﬃths & Garthwaite, 2001). NO is a non-polar mol-
ecule that can selectively partition into the cell mem-
branes. Malinski et al. (1993) used a NO selective
porphyrinic sensor to measure the NO concentrations
in diﬀerent regions of endothelial cells and found signif-
icantly higher concentrations of NO within the endothe-
lial cell membrane in comparison to the concentrations
in the cytosol. This relatively high concentration of
NO in the membrane might prevent diﬀusion of NO
from the cell because the relatively lower levels of NO
in the cytoplasm would be blocked from leaving the cell
by the high concentrations of NO in the membrane. It is
also possible that membrane surface thiols may regulate
the cellular entry of NO, which could in turn regulate its
exit. Finally, protein disulﬁde isomerase (PDI) is able to
catalyze thio-disulﬁde exchange reactions to facilitate
the transfer of NO from the extracellular to the intracel-
lular compartments (Zai, Rudd, Scribner, & Loscalzo,
1999). Thus enzymes like PDI could serve to transport
any NO that leaves the cell, back into the cell using a
mechanism involving transnitrosation.
4.3. Methodological considerations
There are a number of reports which have raised var-
ious issues in relation to potential diﬃculties in using
DAF to image NO production. Roychowdhury, Luthe,
Keilhoﬀ, Wolf, and Horn (2002) report that DAF is
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not supported by the present colocalizations of NO-IF
and cGMP-LI in the same cells, as it is NO that activates
sGC. Their observations perhaps represent a unique sit-
uation that occurs in glial cultures, but does not occur in
retina. Our results supporting that DAF does react with
NO are consistent with the original reports by Kojima
et al. (1998a, 1998b) who state that DAF does not react
with nitrate, nitrite, superoxide, hydrogen peroxide, or
peroxynitrite (also Blute, personal communication).
Nagata et al. (1999) report that the reaction of DAF
with NO donors in a ﬂuorescence spectrometer is re-
duced or abolished by catecholamines, ascorbate, and
reducing agents like glutathione. They suggest it is
likely that these compounds serve to trap the NO
and prevent it from reacting with DAF. Endogenous
catecholamines are only a problem if you want to im-
age NO production within catecholinergic neurons.
More selective synthetic drugs which target catechol-
amine receptors do not inhibit DAF ﬂuorescence (Nag-
ata et al., 1999).
DAF is reported to react not with NO itself, but
with reactive nitrogen oxides such as N2O3. Reducing
agents such as ascorbate or reduced glutathione can
scavenge such reactive nitrogen oxides and thus inhibit
the activation of DAF (Nagata et al., 1999). However,
a recent report by Rodriguez, Specian, Maloney,
Jourdheuil, and Feelisch (2005) has shown that this
is not a critical issue in a cellular environment as op-
posed to a chemical system. DAF is usually applied
as a cell permeable diacetate form which is then
cleaved by intracellular esterases to form a cell imper-
meable DAF which remains trapped in the cells. Using
quantitative high pressure liquid chromatographic
analysis, Rodriguez et al. (2005) estimated the concen-
tration of DAF-related products in the tissue to be
400 lM. They concluded that at these concentrations
DAF could successfully compete with these reducing
agents for the reactive nitrogen oxides. Even in the
presence of these high concentrations of DAF, these
authors concluded that NO production and signaling
remained unchanged in aortic rings. However, these
authors also conclude that although these high intracel-
lular concentrations of DAF can overcome these nitro-
gen oxide scavengers, these high DAF concentrations
can give rise to a background DAF ﬂuorescence which
can limit its eﬀective sensitivity and make basal mea-
surements of NO diﬃcult. The diﬃculty of this back-
ground DAF ﬂuorescence can be minimized by using
lower concentrations of DAF for loading and by care-
ful choice of the emission ﬁlter wavelength used to im-
age the NO-IF. Much of the background DAF
ﬂuorescence is below 515 nm, while much of the NO-
IF of DAF is above this wavelength (Kojima et al.,
1998b). Thus, it is much better to use a long pass emis-
sion ﬁlter with a steep cutoﬀ at 515 nm.Broillet, Randin, and Chatton (2001) report that
DAF is inﬂuenced by factors other than NO, such as
calcium and the light used to image DAF. However, a
subsequent study by Suzuki et al. (2002) using NO gas
itself revealed that the reaction of DAF and NO was
completely independent of calcium and magnesium at
physiological concentrations. Suzuki et al. (2002) also
showed that calcium did not enhance the conversion
of DAF into its ﬂuorescent product (DAF triazole),
but that it enhanced the release of NO from the NO do-
nor used in the Broillet et al. (2001) study. Although our
results did not indicate the activation of DAF by light
(Figs. 4 and 5) it is, however, true that bright light can
release NO that is bound to intracellular sinks like glu-
tathione (Sexton, Muruganandam, McKenney, & Mu-
tus, 1994), therefore it is best to only illuminate the
DAF when images of the NO-IF are being captured.
A number of controls can be used to conﬁrm that the
NO-IF being imaged is due to NO being synthesized by
NOS. The use of a NOS inhibitor can be used to conﬁrm
the enzymatic production of NO as opposed to the re-
lease of NO from bound stores (Fig. 5). It is also valu-
able to try to correlate the changes in NO with a
separate indicator of NO production, such as increased
cGMP levels (Fig. 14) or by measurements using NO
selective electrodes. The involvement of speciﬁc isoforms
of NOS in the production of NO can be analyzed by
colocalizing the increases in NO-IF with immunocyto-
chemically identiﬁed speciﬁc NOS isoforms (Fig. 13).5. Conclusions
NO/cGMP is the most widely distributed signaling
pathway in the retina in that NO can be selectively pro-
duced in every cell type in the retina. The use of NO-IF
imaging and functional NO measurements indicate the
diﬀusion of NO can be largely limited within a single cell
or even a single synaptic bouton, or in other cases there
can be signiﬁcant diﬀusion. The correlation of NO pro-
duction with cGMP synthesis suggests that NO can
function as both an intra- and intercellular signaling
molecule. The application of NO imaging has been cru-
cial to establish much of what is currently known about
NO in the retina and it will form the basis of many fu-
ture studies. Although these imaging techniques and
methods for analyzing the NO/cGMP signaling path-
way have focused on the retina, all of these same meth-
ods are broadly applicable to all neural systems.Acknowledgments
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